BRIEF published on 02/13/2025 at 07:05, 1 month 14 days ago SCHOTT Pharma débute l'année fiscale 2025 avec des résultats prometteurs Marge EBITDA Croissance Des Revenus Résultats Du Premier Trimestre Des Solutions À Haute Valeur Ajoutée Segment DCS
BRIEF published on 02/13/2025 at 07:05, 1 month 14 days ago SCHOTT Pharma Begins Fiscal Year 2025 with Promising Results Revenue Growth EBITDA Margin Q1 Results High-value Solutions DCS Segment
PRESS RELEASE published on 02/13/2025 at 07:00, 1 month 14 days ago SCHOTT Pharma records good start into fiscal year and confirms full year outlook SCHOTT Pharma reports good start in Q1 2025 with EUR 230m revenues, confirms full year outlook. EBITDA margin at 25.1% as reported. High-value solutions share at 55% Revenues EBITDA Margin SCHOTT Pharma Full Year Outlook Q1 2025
BRIEF published on 02/04/2025 at 18:27, 1 month 22 days ago SCHOTT Pharma organise avec succès son assemblée générale annuelle SCHOTT Pharma Assemblée Générale Annuelle Approbation Des Actionnaires Croissance Des Bénéfices Promotion MDAX
BRIEF published on 02/04/2025 at 18:27, 1 month 22 days ago SCHOTT Pharma Holds Successful Annual General Meeting Annual General Meeting Shareholder Approval SCHOTT Pharma Profit Growth MDAX Promotion
PRESS RELEASE published on 02/04/2025 at 18:22, 1 month 22 days ago SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items SCHOTT Pharma's successful Annual General Meeting for FY 2024 with all agenda items approved by shareholders, including new Supervisory Board member Dr. Wolfram Carius and KPMG as new auditor Annual General Meeting Shareholders SCHOTT Pharma KPMG Dr. Wolfram Carius
BRIEF published on 12/12/2024 at 07:05, 3 months 15 days ago SCHOTT Pharma Reports Strong Growth and Record Margins for FY 2024 Revenue Growth EBITDA Margin High-value Solutions Drug Delivery Systems Innovation And Expansion
BRIEF published on 12/12/2024 at 07:05, 3 months 15 days ago SCHOTT Pharma annonce une forte croissance et des marges record pour l'exercice 2024 Marge EBITDA Croissance Des Revenus Systèmes D'administration De Médicaments Des Solutions À Haute Valeur Ajoutée Innovation Et Expansion
PRESS RELEASE published on 12/12/2024 at 07:00, 3 months 15 days ago SCHOTT Pharma with strong growth and record margin after solid year-end finish SCHOTT Pharma AG & Co. KGaA reports strong growth and record margin for the fiscal year 2024, meeting 12% revenue growth target and achieving EBITDA margin of 27.8% Innovation Revenue EBITDA Margin SCHOTT Pharma Growth
BRIEF published on 12/04/2024 at 11:05, 3 months 23 days ago SCHOTT Pharma Introduces Efficient and Sustainable Cartridge Nest Design Sustainability GLP-1 Therapies Pharmaceutical Efficiency Cartridge Design Innovative Packaging
Published on 03/27/2025 at 13:30, 37 minutes ago Jaguar Health Meeting with FDA Regarding Results of Phase 3 OnTarget Study
Published on 03/27/2025 at 13:30, 37 minutes ago Pathfinder Provides Update on Communities and RV Park Portfolio. Spring 2025 Reservations Increase 48% Year-Over-Year
Published on 03/27/2025 at 13:30, 37 minutes ago Nextech3D.ai Advances its AI First Initiative With The Integration of an AI-Powered Chat Agent
Published on 03/27/2025 at 13:10, 57 minutes ago RLTRs Real Intelligence "RI" to Add Professional Quality Video with Premium Accounts
Published on 03/27/2025 at 13:00, 1 hour 7 minutes ago Loop Industries to Participate in Gabelli Funds’ 11th Annual Waste & Sustainability Symposium
Published on 03/27/2025 at 13:00, 1 hour 6 minutes ago Coinsilium Group Limited: Highlights from the Official Launch of Forza! Gibraltar – Opening Addresses & Keynote Presentation
Published on 03/27/2025 at 12:30, 1 hour 36 minutes ago LLB announces successful bond issue of CHF 200 million
Published on 03/27/2025 at 12:24, 1 hour 42 minutes ago Press release: Leonteq publishes results of its Annual General Meeting 2025
Published on 03/27/2025 at 12:18, 1 hour 48 minutes ago Commerzbank successfully completes share buyback of €400 m
Published on 03/27/2025 at 12:15, 1 hour 51 minutes ago LUDWIG BECK – Consolidated financial statements as of December 31, 2024
Published on 03/26/2025 at 18:11, 19 hours 55 minutes ago information-réglementée-26-mars-2025-mise-à-disposition-du-deu-2024
Published on 03/26/2025 at 18:11, 19 hours 55 minutes ago regulated-information-26-march-2025-filing-of-2024-universal-registration-document
Published on 03/26/2025 at 18:05, 20 hours 2 minutes ago Mise à disposition du Document d’Enregistrement Universel 2024 de Schneider Electric
Published on 03/26/2025 at 18:05, 20 hours 2 minutes ago Schneider Electric’s 2024 Universal Registration Document now available
